Half-dose aprotinin preserves hemostatic function in patients undergoing bypass operations
- 30 June 1995
- journal article
- clinical trial
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 59 (6) , 1534-1540
- https://doi.org/10.1016/0003-4975(95)00240-l
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Aprotinin for coronary bypass operations: Efficacy, safety, and influence on early saphenous vein graft patencyThe Journal of Thoracic and Cardiovascular Surgery, 1994
- Reduction of heparin binding to and inhibition of platelets by aprotininThe Annals of Thoracic Surgery, 1993
- Effect of Reduced Aprotinin Dosage on Blood Loss and Use of Blood Products in Patients Undergoing Cardiopulmonary BypassScandinavian Journal of Thoracic and Cardiovascular Surgery, 1993
- Aprotinin therapy for reoperative myocardial revascularization: A placebo-controlled studyThe Annals of Thoracic Surgery, 1992
- Effect of high-dose aprotinin on blood cell filterability in association with cardiopulmonary bypassCoronary Artery Disease, 1992
- Low dose Aprotinin as blood saver in open heart surgeryEuropean Journal of Cardio-Thoracic Surgery, 1991
- Bleeding complications associated with cardiopulmonary bypassBlood, 1990
- Effects of Aprotinin on Hemostatic Mechanisms during Cardiopulmonary BypassThe Annals of Thoracic Surgery, 1987
- EFFECT OF APROTININ ON NEED FOR BLOOD TRANSFUSION AFTER REPEAT OPEN-HEART SURGERYThe Lancet, 1987
- Gerinnungsphysiologische Schnellmethode zur Bestimmung des FibrinogensActa Haematologica, 1957